Market Opportunities in Krill Oil
18 May 2017 | Aker BioMarine
Aker BioMarine recently reported how the company managed to grow sales and improve operations in the still-challenging omega-3 market, and continues to heavily invest in new technology and the development of new krill-derived products. Matts Johansen, CEO of Aker BioMarine, is satisfied with the result, but admitted that 2016 was still a challenging year for the company. Johansen said. “Although 2016 was a good year for Aker BioMarine, we posted slightly negative earnings after tax. The investments needed to build a supply chain for krill-based products, the resources needed to innovate and document their biological effects, and the time needed to develop new markets are reflected in our earnings.”
